Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $1.86 billion. The enterprise value is $1.87 billion.
| Market Cap | 1.86B |
| Enterprise Value | 1.87B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 47.13 million shares outstanding. The number of shares has increased by 24.56% in one year.
| Shares Outstanding | 47.13M |
| Shares Change (YoY) | +24.56% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 124.11% |
| Float | 35.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 104.17 |
| PS Ratio | 8.31 |
| Forward PS | 5.45 |
| PB Ratio | 7.93 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 1.31.
| Current Ratio | 3.68 |
| Quick Ratio | 3.38 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.88 |
Financial Efficiency
Return on equity (ROE) is -76.30% and return on invested capital (ROIC) is -20.01%.
| Return on Equity (ROE) | -76.30% |
| Return on Assets (ROA) | -26.50% |
| Return on Capital (ROIC) | -20.01% |
| Revenue Per Employee | $848,477 |
| Profits Per Employee | -$600,621 |
| Employee Count | 264 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 4.24 |
Taxes
In the past 12 months, MIRM has paid $1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.02% in the last 52 weeks. The beta is 1.15, so MIRM's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +49.02% |
| 50-Day Moving Average | 29.85 |
| 200-Day Moving Average | 28.61 |
| Relative Strength Index (RSI) | 67.58 |
| Average Volume (20 Days) | 962,306 |
Short Selling Information
The latest short interest is 7.15 million, so 15.16% of the outstanding shares have been sold short.
| Short Interest | 7.15M |
| Short Previous Month | 7.80M |
| Short % of Shares Out | 15.16% |
| Short % of Float | 20.20% |
| Short Ratio (days to cover) | 6.63 |
Income Statement
In the last 12 months, MIRM had revenue of $224.00 million and -$158.56 million in losses. Loss per share was -$3.77.
| Revenue | 224.00M |
| Gross Profit | 164.11M |
| Operating Income | -108.47M |
| Pretax Income | -157.15M |
| Net Income | -158.56M |
| EBITDA | -127.08M |
| EBIT | -142.71M |
| Loss Per Share | -$3.77 |
Balance Sheet
The company has $302.84 million in cash and $307.52 million in debt, giving a net cash position of -$4.68 million or -$0.10 per share.
| Cash & Cash Equivalents | 302.84M |
| Total Debt | 307.52M |
| Net Cash | -4.68M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 234.60M |
| Book Value Per Share | 4.98 |
| Working Capital | 283.56M |
Cash Flow
In the last 12 months, operating cash flow was -$21.96 million and capital expenditures -$81,000, giving a free cash flow of -$22.04 million.
| Operating Cash Flow | -21.96M |
| Capital Expenditures | -81,000 |
| Free Cash Flow | -22.04M |
| FCF Per Share | -$0.47 |
Margins
Gross margin is 73.26%, with operating and profit margins of -48.43% and -70.79%.
| Gross Margin | 73.26% |
| Operating Margin | -48.43% |
| Pretax Margin | -70.16% |
| Profit Margin | -70.79% |
| EBITDA Margin | -56.73% |
| EBIT Margin | -63.71% |
| FCF Margin | -9.84% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.56% |
| Shareholder Yield | -24.56% |
| Earnings Yield | -8.52% |
| FCF Yield | -1.18% |
Analyst Forecast
The average price target for MIRM is $53.54, which is 35.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.54 |
| Price Target Difference | 35.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 36.49% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 3 |